Tygh Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.43M | Sell |
|
|||||
|
2020
Q3 | $8.29M | Sell |
|
|||||
|
2020
Q2 | $14M | Sell |
|
|||||
|
2020
Q1 | $11M | Buy |
|
|||||
|
2019
Q4 | $5.81M | Buy |
|
|||||
|
2019
Q3 | $3.26M | Sell |
|
|||||
|
2019
Q2 | $6.83M | Buy |
|
|||||
|
2019
Q1 | $6.1M | Sell |
|
|||||
|
2018
Q4 | $10.9M | Buy |
|
|||||
|
2018
Q3 | $10.6M | Sell |
|
|||||
|
2018
Q2 | $10.3M | Sell |
|
|||||
|
2018
Q1 | $8.34M | Buy |
|
|||||
|
2017
Q4 | $6.69M | Sell |
|
|||||
|
2017
Q3 | $10.6M | Buy |
|
|||||
|
2017
Q2 | $7.18M | Buy |
|